Evidence map›Paper›PMID 39505987›Full record

ArticleScientific reports2024

Author Correction: Preclinical comparison of prolgolimab, pembrolizumab and nivolumab.

Aleksandr Gordeev, Andrei Vaal, Maria Puchkova, Iana Smirnova, Aleksandr Doronin, Anna Znobishcheva, Daria Zhmudanova, Aleksei Aleksandrov, Mikhail Sukchev, Evgeny Imyanitov and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Aleksandr GordeevJSC BIOCAD, St.-Petersburg, Russia. gordeevaa@biocad.ru.
Andrei VaalJSC BIOCAD, St.-Petersburg, Russia.
Maria PuchkovaJSC BIOCAD, St.-Petersburg, Russia.
Iana SmirnovaJSC BIOCAD, St.-Petersburg, Russia.
Aleksandr DoroninJSC BIOCAD, St.-Petersburg, Russia.
Anna ZnobishchevaJSC BIOCAD, St.-Petersburg, Russia.
Daria ZhmudanovaJSC BIOCAD, St.-Petersburg, Russia.
Aleksei AleksandrovJSC BIOCAD, St.-Petersburg, Russia.
Mikhail SukchevJSC BIOCAD, St.-Petersburg, Russia.
Evgeny ImyanitovDepartment of Tumor Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.
Valery SolovyevJSC BIOCAD, St.-Petersburg, Russia.
Pavel IakovlevJSC BIOCAD, St.-Petersburg, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39505987
PMCPMC11541495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.